Annual Total Long Term Liabilities
$15.47 M
-$239.00 K-1.52%
31 December 2023
Summary:
Evogene annual total long term liabilities is currently $15.47 million, with the most recent change of -$239.00 thousand (-1.52%) on 31 December 2023. During the last 3 years, it has risen by +$10.12 million (+188.82%). EVGN annual total long term liabilities is now -1.52% below its all-time high of $15.71 million, reached on 31 December 2022.EVGN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$4.59 M
-$155.00 K-3.27%
30 September 2024
Summary:
Evogene quarterly total long term liabilities is currently $4.59 million, with the most recent change of -$155.00 thousand (-3.27%) on 30 September 2024. Over the past year, it has dropped by -$10.81 million (-70.21%). EVGN quarterly long term liabilities is now -71.04% below its all-time high of $15.84 million, reached on 30 June 2023.EVGN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.5% | -70.2% |
| 3 y3 years | +188.8% | -24.6% |
| 5 y5 years | +423.2% | -17.8% |
EVGN Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.5% | +188.8% | -71.0% | at low |
| 5 y | 5 years | -1.5% | +423.2% | -71.0% | at low |
| alltime | all time | -1.5% | +423.2% | -71.0% | +63.8% |
Evogene Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.59 M(-3.3%) |
| June 2024 | - | $4.74 M(-68.9%) |
| Mar 2024 | - | $15.27 M(-1.3%) |
| Dec 2023 | $15.47 M(-1.5%) | $15.47 M(+0.5%) |
| Sept 2023 | - | $15.40 M(-2.8%) |
| June 2023 | - | $15.84 M(+1.4%) |
| Mar 2023 | - | $15.62 M(-0.6%) |
| Dec 2022 | $15.71 M(+161.8%) | $15.71 M(+1.3%) |
| Sept 2022 | - | $15.51 M(+170.9%) |
| June 2022 | - | $5.72 M(-2.5%) |
| Mar 2022 | - | $5.87 M(-2.2%) |
| Dec 2021 | $6.00 M(+12.0%) | $6.00 M(-1.4%) |
| Sept 2021 | - | $6.09 M(+9.3%) |
| June 2021 | - | $5.57 M(+4.4%) |
| Mar 2021 | - | $5.33 M(-0.5%) |
| Dec 2020 | $5.36 M(-0.8%) | $5.36 M(+1.5%) |
| Sept 2020 | - | $5.28 M(-0.7%) |
| June 2020 | - | $5.31 M(+1.7%) |
| Mar 2020 | - | $5.22 M(-3.4%) |
| Dec 2019 | $5.40 M(+82.7%) | $5.40 M(-3.2%) |
| Sept 2019 | - | $5.58 M(-5.2%) |
| June 2019 | - | $5.88 M(+4.4%) |
| Mar 2019 | - | $5.63 M(+90.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $2.96 M(-16.9%) | $2.96 M(+4.5%) |
| Sept 2018 | - | $2.83 M(-11.3%) |
| June 2018 | - | $3.19 M(+4.6%) |
| Mar 2018 | - | $3.05 M(-14.3%) |
| Dec 2017 | $3.56 M(+2.5%) | $3.56 M(+3.5%) |
| Sept 2017 | - | $3.44 M(-1.1%) |
| June 2017 | - | $3.48 M(+18.9%) |
| Mar 2017 | - | $2.93 M(-15.7%) |
| Dec 2016 | $3.47 M(+8.4%) | $3.47 M(+18.5%) |
| Sept 2016 | - | $2.93 M(+4.6%) |
| June 2016 | - | $2.80 M(-10.5%) |
| Mar 2016 | - | $3.13 M(-2.3%) |
| Dec 2015 | $3.20 M(-10.6%) | $3.20 M(-9.3%) |
| Sept 2015 | - | $3.53 M(-12.1%) |
| June 2015 | - | $4.02 M(+1.5%) |
| Mar 2015 | - | $3.96 M(+10.4%) |
| Dec 2014 | $3.58 M(-10.2%) | $3.58 M(+10.7%) |
| Sept 2014 | - | $3.24 M(-8.1%) |
| June 2014 | - | $3.52 M(+0.7%) |
| Mar 2014 | - | $3.50 M(-12.3%) |
| Dec 2013 | $3.99 M(-43.8%) | $3.99 M(-16.3%) |
| Sept 2013 | - | $4.76 M(-15.8%) |
| June 2013 | - | $5.66 M(-20.3%) |
| Dec 2012 | $7.10 M | $7.10 M |
FAQ
- What is Evogene annual total long term liabilities?
- What is the all time high annual total long term liabilities for Evogene?
- What is Evogene annual total long term liabilities year-on-year change?
- What is Evogene quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Evogene?
- What is Evogene quarterly long term liabilities year-on-year change?
What is Evogene annual total long term liabilities?
The current annual total long term liabilities of EVGN is $15.47 M
What is the all time high annual total long term liabilities for Evogene?
Evogene all-time high annual total long term liabilities is $15.71 M
What is Evogene annual total long term liabilities year-on-year change?
Over the past year, EVGN annual total long term liabilities has changed by -$239.00 K (-1.52%)
What is Evogene quarterly total long term liabilities?
The current quarterly long term liabilities of EVGN is $4.59 M
What is the all time high quarterly long term liabilities for Evogene?
Evogene all-time high quarterly total long term liabilities is $15.84 M
What is Evogene quarterly long term liabilities year-on-year change?
Over the past year, EVGN quarterly total long term liabilities has changed by -$10.81 M (-70.21%)